medcentres plc

Live EstablishedSmallDeclining

medcentres plc Company Information

Share MEDCENTRES PLC

Company Number

06035172

Shareholders

deirdre arnold

nicolas arnold

Group Structure

View All

Industry

Buying and selling of own real estate

 +3

Registered Address

1st floor highfield house, bartons road, fordingbridge, hants, SP6 1JD

medcentres plc Estimated Valuation

£2.4m

Pomanda estimates the enterprise value of MEDCENTRES PLC at £2.4m based on a Turnover of £2.3m and 1.06x industry multiple (adjusted for size and gross margin).

medcentres plc Estimated Valuation

£1m

Pomanda estimates the enterprise value of MEDCENTRES PLC at £1m based on an EBITDA of £237.6k and a 4.35x industry multiple (adjusted for size and gross margin).

medcentres plc Estimated Valuation

£9.7m

Pomanda estimates the enterprise value of MEDCENTRES PLC at £9.7m based on Net Assets of £5m and 1.93x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Medcentres Plc Overview

Medcentres Plc is a live company located in fordingbridge, SP6 1JD with a Companies House number of 06035172. It operates in the development of building projects sector, SIC Code 41100. Founded in December 2006, it's largest shareholder is deirdre arnold with a 50% stake. Medcentres Plc is a established, small sized company, Pomanda has estimated its turnover at £2.3m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Medcentres Plc Health Check

Pomanda's financial health check has awarded Medcentres Plc a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

2 Strong

positive_score

4 Regular

positive_score

6 Weak

size

Size

annual sales of £2.3m, make it smaller than the average company (£5.9m)

£2.3m - Medcentres Plc

£5.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (7.1%)

-2% - Medcentres Plc

7.1% - Industry AVG

production

Production

with a gross margin of 38.5%, this company has a comparable cost of product (46.3%)

38.5% - Medcentres Plc

46.3% - Industry AVG

profitability

Profitability

an operating margin of 9.7% make it less profitable than the average company (12.2%)

9.7% - Medcentres Plc

12.2% - Industry AVG

employees

Employees

with 10 employees, this is below the industry average (32)

10 - Medcentres Plc

32 - Industry AVG

paystructure

Pay Structure

on an average salary of £41.9k, the company has an equivalent pay structure (£46.2k)

£41.9k - Medcentres Plc

£46.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £225.3k, this is equally as efficient (£196.5k)

£225.3k - Medcentres Plc

£196.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 164 days, this is later than average (40 days)

164 days - Medcentres Plc

40 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 20 days, this is quicker than average (32 days)

20 days - Medcentres Plc

32 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 70 days, this is less than average (182 days)

70 days - Medcentres Plc

182 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 17 weeks, this is average cash available to meet short term requirements (15 weeks)

17 weeks - Medcentres Plc

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 20.2%, this is a lower level of debt than the average (61%)

20.2% - Medcentres Plc

61% - Industry AVG

MEDCENTRES PLC financials

EXPORTms excel logo

Medcentres Plc's latest turnover from March 2024 is £2.3 million and the company has net assets of £5 million. According to their latest financial statements, Medcentres Plc has 10 employees and maintains cash reserves of £188.2 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Dec 2009
Turnover2,252,7563,565,4633,160,5042,390,7664,678,2394,527,9114,374,110699,713185,2691,149,1571,164,3591,379,2291,107,612
Other Income Or Grants
Cost Of Sales1,386,5093,115,6912,545,8591,775,1993,950,7473,923,3693,697,943163,4794,597349,953452,383676,765753,530
Gross Profit866,247449,772614,645615,567727,492604,542676,167536,234180,672799,204711,976702,464354,082
Admin Expenses647,497529,841502,704540,205715,623-2,305,702686,187509,0551,008,842507,119544,406464,868396,4404,875
Operating Profit218,750-80,069111,94175,36211,8692,910,244-10,02027,179-828,170292,085167,570237,596-42,358-4,875
Interest Payable7941,0334866987,02078,691390,936419,579353,777170,1415,560
Interest Receivable520369119103095822,0803,1981334358,3205,560
Pre-Tax Profit266,876140,667146,655123,76211,9882,909,556-16,73127,2371,825,219-100,761489,749-121,130-208,056-4,875
Tax-36,912-153,939-11,645-17,155-4,164-568,023-27,752-13,794-24,965-99,92764,509-50,252
Profit After Tax229,964-13,272135,010106,6077,8242,341,533-44,48313,4431,800,254-100,761389,822-56,621-258,308-4,875
Dividends Paid
Retained Profit229,964-13,272135,010106,6077,8242,341,533-44,48313,4431,800,254-103,037409,653-40,756-258,265-4,875
Employee Costs418,926339,079360,161319,275357,480231,688200,833201,127156,486287,193312,302343,572344,257
Number Of Employees1010131314131212121818212011
EBITDA*237,574-61,149130,86294,11730,5682,920,19716,85155,066-791,007540,327422,491499,343262,394-4,875

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Dec 2009
Tangible Assets773,087725,921872,341889,522906,278876,529267,294286,41588,3881,149,601997,8471,161,4021,504,214793,856
Intangible Assets-182,699-194,117-205,535-216,953-309,544
Investments & Other2,974,5102,974,5102,849,5122,849,6022,848,5022,636,502210,692210,6921,932,82614,400,40110,364,61011,439,1249,404,3586,101,789
Debtors (Due After 1 year)35,00035,00035,00035,00035,00035,00035,00035,000
Total Fixed Assets3,782,5973,735,4313,756,8533,774,1243,789,7803,548,031512,986532,1072,021,21415,367,30311,168,34012,394,99110,691,6196,586,101
Stock & work in progress269,216268,712268,712268,343268,2081,538,4182,181,1082,164,469153,494
Trade Debtors1,012,966924,358837,160337,505141,832604,077234,567160,87248,875380,449209,714181,466180,17555,477
Group Debtors987,553987,553987,553987,6341,146,8431,231,984574,935714,823646,854827,000748,8101,060,000250,000720,000
Misc Debtors53,153316,884223,101602,453567,3241,273,4341,164,5131,059,4831,076,9951,439,1711,243,692137,028103,700626,964
Cash188,230352,696458,68498,13394,57210,293385,93567,838229,307165,0381,147,4781,634,5241,263,6463,809,009
misc current assets
total current assets2,511,1182,850,2032,775,2102,294,0682,218,7794,658,2064,541,0584,167,4852,002,0312,811,6583,349,6943,013,0181,797,5215,364,944
total assets6,293,7156,585,6346,532,0636,068,1926,008,5598,206,2375,054,0444,699,5924,023,24518,178,96114,518,03415,408,00912,489,14011,951,045
Bank overdraft
Bank loan10,00010,00010,0005,000262,823160,279146,165167,662116,31127,646
Trade Creditors 77,82264,16765,90891,89791,525405,420785,254143,35271,985107,43984,475309,994147,177149,000
Group/Directors Accounts177,410177,410177,410178,130236,564255,204168,283987,1461,098,14616,956645,821
other short term finances
hp & lease commitments
other current liabilities464,712991,257900,528540,206635,5842,514,4741,554,7752,041,925622,7701,501,8451,457,244249,460551,725188,928
total current liabilities552,5341,065,4241,153,846814,513904,5193,098,0242,839,4162,440,481863,0382,756,7092,786,030744,072815,2131,011,395
loans16,66726,66736,66745,00010,005,26610,172,17613,493,93110,382,7919,927,406
hp & lease commitments
Accruals and Deferred Income
other liabilities914,539
provisions702,220701,213535,948538,087540,055552,05264,50914,273
total long term liabilities718,887727,880572,615583,087540,055552,052914,53910,005,26610,172,17613,493,93110,447,3009,941,679
total liabilities1,271,4211,793,3041,726,4611,397,6001,444,5743,650,0762,839,4162,440,4811,777,57712,761,97512,958,20614,238,00311,262,51310,953,074
net assets5,022,2944,792,3304,805,6024,670,5924,563,9854,556,1612,214,6282,259,1112,245,6685,412,9001,558,0181,148,3651,189,121965,116
total shareholders funds5,022,2944,792,3304,805,6024,670,5924,563,9854,556,1612,214,6282,259,1112,245,6685,412,9001,558,0181,148,3651,189,121965,116
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Dec 2009
Operating Activities
Operating Profit218,750-80,069111,94175,36211,8692,910,244-10,02027,179-828,170292,085167,570237,596-42,358-4,875
Depreciation18,82418,92018,92118,75518,6999,95326,87127,88737,163259,660266,339273,165316,170
Amortisation-11,418-11,418-11,418-11,418
Tax-36,912-153,939-11,645-17,155-4,164-568,023-27,752-13,794-24,965-99,92764,509-50,252
Stock504369135-1,270,210-642,69016,6392,164,469-153,494153,494
Debtors-175,123180,981120,22271,593-1,253,4961,135,48038,837197,454-873,896444,404823,722844,619-868,5661,402,441
Creditors13,655-1,741-25,989372-313,895-379,834641,90271,367-35,45422,964-225,519162,817-1,823149,000
Accruals and Deferred Income-526,54590,729360,322-95,378-1,878,890959,699-487,1501,419,155-879,07544,6011,207,784-302,265362,797188,928
Deferred Taxes & Provisions1,007165,265-2,139-1,968-11,997552,052-64,50950,23614,273
Cash flow from operations-136,602-141,816330,820-91,740345,3282,991,30188,375-830,129-856,605163,488481,107-484,7241,645,412-1,208,609
Investing Activities
capital expenditure-161,536-7,750-91278,243-234,3941,994,400-2,830,863-3,808,298-1,786,539
Change in Investments124,998-901,100212,0002,425,810-1,722,134-12,467,5754,035,791-1,074,5142,034,7663,302,5696,101,789
cash flow from investments-124,99890-1,100-212,000-2,587,346-7,7501,721,22212,545,818-4,270,1853,068,914-4,865,629-7,110,867-7,888,328
Financing Activities
Bank loans5,0005,000-262,823262,823-160,27914,114-21,49751,35188,66527,646
Group/Directors Accounts-177,410-720-58,434-18,64086,921-818,863-111,0001,081,19016,956-645,821645,821
Other Short Term Loans
Long term loans-10,000-10,000-8,33345,000-10,005,266-166,910-3,321,7553,111,140455,3859,927,406
Hire Purchase and Lease Commitments
other long term liabilities-914,539914,539
share issue-4,967,4863,957,919482,270969,991
interest-274-664-486119-688-6,71158-56,611-387,738-419,446-353,342-161,821
cash flow from financing-10,274-188,074-3,81950,000-601-321,945237,472-827,560-15,093,9663,306,385-2,681,5082,826,105218,67811,570,864
cash and cash equivalents
cash-164,466-105,988360,5513,56184,279-375,642318,097-161,46964,269-982,440-487,046370,878-2,545,3633,809,009
overdraft
change in cash-164,466-105,988360,5513,56184,279-375,642318,097-161,46964,269-982,440-487,046370,878-2,545,3633,809,009

medcentres plc Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medcentres plc. Get real-time insights into medcentres plc's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Medcentres Plc Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for medcentres plc by selecting its closest rivals, whether from the CONSTRUCTION sector, other small companies, companies in SP6 area or any other competitors across 12 key performance metrics.

medcentres plc Ownership

MEDCENTRES PLC group structure

Medcentres Plc has 4 subsidiary companies.

MEDCENTRES PLC Shareholders

deirdre arnold 50%
nicolas arnold 50%

medcentres plc directors

Medcentres Plc currently has 6 directors. The longest serving directors include Mr Nicolas Arnold (Dec 2006) and Ms Deirdre Arnold (Jan 2007).

officercountryagestartendrole
Mr Nicolas Arnold65 years Dec 2006- Director
Ms Deirdre Arnold66 years Jan 2007- Director
Mr Michael Arnold38 years Oct 2013- Director
Mr David Chilcott59 years Oct 2015- Director
Mr James Arnold35 years Apr 2017- Director
Mr David ArnoldEngland31 years Jul 2018- Director

P&L

March 2024

turnover

2.3m

-37%

operating profit

218.8k

-373%

gross margin

38.5%

+204.83%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

5m

+0.05%

total assets

6.3m

-0.04%

cash

188.2k

-0.47%

net assets

Total assets minus all liabilities

medcentres plc company details

company number

06035172

Type

Public limited with Share Capital

industry

68100 - Buying and selling of own real estate

70229 - Management consultancy activities (other than financial management)

70100 - Activities of head offices

incorporation date

December 2006

age

19

incorporated

UK

ultimate parent company

None

accounts

Full Accounts

last accounts submitted

March 2024

previous names

N/A

accountant

-

auditor

FLETCHER & PARTNERS

address

1st floor highfield house, bartons road, fordingbridge, hants, SP6 1JD

Bank

THE ROYAL BANK OF SCOTLAND PLC, THE ROYAL BANK OF SCOTLAND PLC, THE ROYAL BANK OF SCOTLAND PLC

Legal Advisor

-

medcentres plc Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to medcentres plc. Currently there are 3 open charges and 0 have been satisfied in the past.

medcentres plc Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEDCENTRES PLC. This can take several minutes, an email will notify you when this has completed.

medcentres plc Companies House Filings - See Documents

datedescriptionview/download